BKV Form 4: Officer sold 10,000 shares under 10b5-1 plan

Rhea-AI Filing Summary

Larrick Lindsay B, Chief Legal and Administrative Officer of BKV Corp (BKV) reported a sale of common stock executed on 08/12/2025 under a pre-established Rule 10b5-1 trading plan adopted on 11/22/2024. The report shows 10,000 shares sold at $21.62 per share, with the reporting person holding 200,528 shares following the transaction. The Form 4 was submitted by one reporting person and signed by an attorney-in-fact. This disclosure documents an insider liquidity event executed under an affirmative defense trading plan and the officer’s continuing direct ownership position in the company.

Positive

• Transaction executed under a Rule 10b5-1 plan, which provides an affirmative defense and reduces concerns about opportunistic timing
• Significant retained stake post-transaction: the officer still holds 200,528 shares, indicating continued alignment with shareholders

Negative

• Insider sold 10,000 shares, representing a reduction in direct holdings that investors may view as insider liquidity

Insights

Securities Analyst

TL;DR: Routine insider sale under a 10b5-1 plan; modest size relative to the remaining holding.

The sale of 10,000 shares at $21.62 was executed pursuant to a Rule 10b5-1 plan adopted 11/22/2024, which typically reduces timing concerns about opportunistic insider trades. The filing reports 200,528 shares held post-transaction, indicating the officer retains a meaningful direct stake. For investors, this is a disclosed liquidity event rather than an unexplained, ad hoc sale; its immediate market impact is likely limited absent additional context on company size or total outstanding shares.

Corporate Governance Expert

TL;DR: Proper governance disclosure: trade executed under a documented 10b5-1 plan and reported on Form 4.

The Form 4 identifies the reporting person as an officer (Chief Legal and Admin Officer) and confirms the transaction was made under an existing 10b5-1 trading plan adopted on 11/22/2024, which supports compliance with insider-trading policies. The signature by an attorney-in-fact is noted. This filing satisfies Section 16 reporting requirements by disclosing the transaction amount, price, and resulting beneficial ownership, which preserves transparency for shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larrick Lindsay B

(Last) (First) (Middle)

1200 17TH STREET, SUITE 2100

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal and Admin Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2025		S(1)		10,000	D	$21.62	200,528	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2024.

Remarks:

	/s/ Kathleen Lenox, attorney-in-fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the BKV Form 4 filed for Larrick Lindsay B disclose?

The Form 4 discloses a sale of 10,000 shares of BKV common stock at $21.62 per share executed on 08/12/2025 under a Rule 10b5-1 trading plan.

Was the sale by the BKV officer part of a pre-established trading plan?

Yes. The filing states the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on 11/22/2024.

How many BKV shares does the reporting officer hold after the transaction?

The report shows the officer beneficially owns 200,528 shares following the reported transaction.

Who signed the Form 4 for the BKV insider transaction?

The Form 4 was signed by Kathleen Lenox, attorney-in-fact on behalf of the reporting person.

Does the Form 4 indicate multiple reporting persons filed this form?

No. The form indicates it was filed by one reporting person.